Circulating microRNA in lung cancer

doi:10.3760/cma.j.issn.1673422X.2015.09.014

Abstract

QU Li-Li, LIU Xiao-Qing. Circulating microRNA in lung cancer[J]. Journal of International Oncology, 2015, 42(8): 693-.

［1］ Lan H, Lu H, Wang X, et al. MicroRNAs as potential biomarkers in cancer: opportunities and challenges［J］. Biomed Res Int, 2015, 2015:125094. ［2］ Price C, Chen J. MicroRNAs in cancer biology and therapy: current status and perspectives［J］. Genes Dis, 2014, 1(1):5363. ［3］ Frank B, Maximilian FR. MicroRNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?［J］. Theranostics, 2013, 3(12):943952. ［4］ Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communications in cardiovascular disease［J］. Circ Res, 2012, 110(3):483495. ［5］ Haque R, Hur EH, Farrell AN, et al. MicroRNA152 represses VEGF and TGFβ1 expressions through posttranscriptional inhibition of prorenin receptor in human retinal endothelial cells［J］. Mol Vis, 2015, 21:224235. ［6］ Taft RJ, Pang KC, Mercer TR, et al. Noncoding RNAs: regulators of disease［J］. J Pathol, 2010, 220(2):126139. ［7］ Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large Bcell lymphoma［J］. Br J Haematol, 2008, 141(5):672675. ［8］ Chen X, Ba Y, Ma L, et al. Criculation of micorRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases［J］. Cell Res, 2008, 18(10):9971006. ［9］ Brase JC, Wutting D, Kuner R, et al. Serum microRNAs as noninvasive biomarkers for cancer ［J］. Mol Cancer, 2010,9:306314. ［10］ Kroh EM, Parkin PK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcriptionPCR(qRTPCR)［J］. Methods, 2010,50（4）: 298301. ［11］ McDonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges［J］. Clin Chem, 2011,57（6）:833840. ［12］ Camarillo C, Swerdel M, Hart RP. Comparison of microarray and quantitative realtime PCR methods for measuring microRNA levels in MSC cultures［J］. Methods Mol Biol, 2011,698:419429. ［13］ Bianchi F, Nicassio F, Verones G, et al. Circulating microRNAs: next generation biomarkers for early lung cancer detection［J］. Ecancermedicalscience, 2012, 6:246. ［14］ Aushev VA, Zborovshaya IB, Laktionov K, et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma［J］. PLoS One, 2013, 8(10):e78649. ［15］ Kaduthanam S, Gade S, Meister M, et al. Serum miR1423p is associated with early relapse in operable lung adenocarcinoma patients［J］. Lung Cancer, 2013, 80(2):223227. ［16］ Franchina T, Amodeo V, Bronte G, et al. Circulating miR22, miR24 and miR34a as novel predictive biomarkers to pemetrexedbased chemotherapy in advanced nonsmall cell lung cancer［J］. J Cell Physiol, 2014, 229(1):9799. ［17］ Zhang H, Su Y, Xu F, et al. Circulating microRNAs in relation to EGFR status and survival fo lung adenocarcinoma in female nonsmokers［J］. PLoS One, 2013, 8(11):e81408. ［18］ Markou A, Sourvinou I, Vorkas PA, et al. Clinical evaluation of microRNA expression profiling in non small cell lung cancer［J］. Lung Cancer, 2013, 81(3):388396.

Circulating microRNA in lung cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments